TY - JOUR
T1 - Kidney function and sudden cardiac death in the community
T2 - The Atherosclerosis Risk in Communities (ARIC) Study
AU - Suzuki, Takeki
AU - Agarwal, Sunil K.
AU - Deo, Rajat
AU - Sotoodehnia, Nona
AU - Grams, Morgan E.
AU - Selvin, Elizabeth
AU - Calkins, Hugh
AU - Rosamond, Wayne
AU - Tomaselli, Gordon
AU - Coresh, Josef
AU - Matsushita, Kunihiro
N1 - Funding Information:
Funding sources: The ARIC Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts ( HHSN268201100005C , HHSN268201100006C , HHSN268201100007C , HHSN268201100008C , HHSN268201100009C , HHSN268201100010C , HHSN268201100011C , and HHSN268201100012C ). This research was also supported by an unrestricted research fund from Kyowa Hakko Kirin to Dr. Matsushita and NIH/NIDDK grants K24DK106414 and R01DK089174 to Dr Selvin.
Funding Information:
Dr Sotoodehnia was supported by HL111089, HL116747, and the Laughlin Family. Dr Selvin reports grants from National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases during the conduct of the study and personal fees from Roche Diagnostics outside the submitted work. Dr Calkins reports personal fees from Medtronic, St Jude Medical, Atricure, Abbott, and Boerringer Inglheim outside the submitted work. Dr. Matsushita reports unrestricted research funding (partially supporting the submitted work) and personal fee (outside the submitted work) from Kyowa Hakko Kirin. The other authors declare that they have no relevant financial interests.
Publisher Copyright:
© 2016 Elsevier, Inc.
PY - 2016/10/1
Y1 - 2016/10/1
N2 - Individuals with chronic kidney disease, particularly those requiring dialysis, are at high risk of sudden cardiac death (SCD). However, comprehensive data for the full spectrum of kidney function and SCD risk in the community are sparse. Furthermore, newly developed equations for estimated glomerular filtration rate (eGFR) and novel filtration markers might add further insight to the role of kidney function in SCD. Methods We investigated the associations of baseline eGFRs using serum creatinine, cystatin C, or both (eGFRcr, eGFRcys, and eGFRcr-cys); cystatin C itself; and β2-microglobulin (B2M) with SCD (205 cases through 2001) among 13,070 black and white ARIC participants at baseline during 1990-1992 using Cox regression models accounting for potential confounders. Results Low eGFR was independently associated with SCD risk: for example, hazard ratio for eGFR <45 versus ≥90 mL/(min 1.73m2) was 3.71 (95% CI 1.74-7.90) with eGFRcr, 5.40 (2.97-9.83) with eGFRcr-cys, and 5.24 (3.01-9.11) with eGFRcys. When eGFRcr and eGFRcys were included together in a single model, the association was only significant for eGFRcys. When three eGFRs, cystatin C, and B2M were divided into quartiles, B2M demonstrated the strongest association with SCD (hazard ratio for fourth quartile vs first quartile 3.48 (2.03-5.96) vs ≤2.7 for the other kidney markers). Conclusions Kidney function was independently and robustly associated with SCD in the community, particularly when cystatin C or B2M was used. These results suggest the potential value of kidney function as a risk factor for SCD and the advantage of novel filtration markers over eGFRcr in this context.
AB - Individuals with chronic kidney disease, particularly those requiring dialysis, are at high risk of sudden cardiac death (SCD). However, comprehensive data for the full spectrum of kidney function and SCD risk in the community are sparse. Furthermore, newly developed equations for estimated glomerular filtration rate (eGFR) and novel filtration markers might add further insight to the role of kidney function in SCD. Methods We investigated the associations of baseline eGFRs using serum creatinine, cystatin C, or both (eGFRcr, eGFRcys, and eGFRcr-cys); cystatin C itself; and β2-microglobulin (B2M) with SCD (205 cases through 2001) among 13,070 black and white ARIC participants at baseline during 1990-1992 using Cox regression models accounting for potential confounders. Results Low eGFR was independently associated with SCD risk: for example, hazard ratio for eGFR <45 versus ≥90 mL/(min 1.73m2) was 3.71 (95% CI 1.74-7.90) with eGFRcr, 5.40 (2.97-9.83) with eGFRcr-cys, and 5.24 (3.01-9.11) with eGFRcys. When eGFRcr and eGFRcys were included together in a single model, the association was only significant for eGFRcys. When three eGFRs, cystatin C, and B2M were divided into quartiles, B2M demonstrated the strongest association with SCD (hazard ratio for fourth quartile vs first quartile 3.48 (2.03-5.96) vs ≤2.7 for the other kidney markers). Conclusions Kidney function was independently and robustly associated with SCD in the community, particularly when cystatin C or B2M was used. These results suggest the potential value of kidney function as a risk factor for SCD and the advantage of novel filtration markers over eGFRcr in this context.
UR - http://www.scopus.com/inward/record.url?scp=84979988128&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84979988128&partnerID=8YFLogxK
U2 - 10.1016/j.ahj.2016.07.004
DO - 10.1016/j.ahj.2016.07.004
M3 - Article
C2 - 27659882
AN - SCOPUS:84979988128
SN - 0002-8703
VL - 180
SP - 46
EP - 53
JO - American Heart Journal
JF - American Heart Journal
ER -